| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| RISPERIDONE (has an active metabolite)
| RISPERIDONE | NERVOUS SYSTEM | ORAL INTRAMUSCULAR SUBCUTANEOUS | Tmax 1 HOUR F 70 PERCENT VD 97.5 LITER (65 KILOGRAM) PPB 90 PERCENT Cl 21 LITER / HOUR HT 3 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | 5-HYDROXYTRYPTAMINE 2A RECEPTOR D(2) DOPAMINE RECEPTOR ALPHA 1 ADRENERGIC RECEPTOR ALPHA 2 ADRENERGIC RECEPTOR H1 HISTAMINIC RECEPTOR PDB 6C38 (STRUCTURE OF THE D2 DOPAMINE RECEPTOR BOUND TO THE ATYPICAL ANTIPSYCHOTIC DRUG RISPERIDONE) LIGAND CODE = 8NU (link to the list of PDB complexes) Download experimental 3D coordinates of 8NU with added hydrogens | D(2) dopamine receptor UNIPROT P14416 DRD2 -- 5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A more at DrugCentral | EMA | |||
